Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer

Bibliographic Details
Main Authors: Alexis Woodward, Benjamin Southard, Sampurna Chakraborty, Aaron O. Bailey, Gabriela N. F. Faria, Patrick McKernan, Wajeeha Razaq, Roger G. Harrison
Format: Article
Language:English
Published: Springer 2024-04-01
Series:Molecular Biomedicine
Online Access:https://doi.org/10.1186/s43556-024-00180-4
_version_ 1827291807493390336
author Alexis Woodward
Benjamin Southard
Sampurna Chakraborty
Aaron O. Bailey
Gabriela N. F. Faria
Patrick McKernan
Wajeeha Razaq
Roger G. Harrison
author_facet Alexis Woodward
Benjamin Southard
Sampurna Chakraborty
Aaron O. Bailey
Gabriela N. F. Faria
Patrick McKernan
Wajeeha Razaq
Roger G. Harrison
author_sort Alexis Woodward
collection DOAJ
first_indexed 2024-04-24T12:44:05Z
format Article
id doaj.art-dd10dc6728754e57b4bed18ff6fc82d8
institution Directory Open Access Journal
issn 2662-8651
language English
last_indexed 2024-04-24T12:44:05Z
publishDate 2024-04-01
publisher Springer
record_format Article
series Molecular Biomedicine
spelling doaj.art-dd10dc6728754e57b4bed18ff6fc82d82024-04-07T11:05:53ZengSpringerMolecular Biomedicine2662-86512024-04-01511610.1186/s43556-024-00180-4Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancerAlexis Woodward0Benjamin Southard1Sampurna Chakraborty2Aaron O. Bailey3Gabriela N. F. Faria4Patrick McKernan5Wajeeha Razaq6Roger G. Harrison7Stephenson School of Biomedical Engineering, University of OklahomaStephenson School of Biomedical Engineering, University of OklahomaStephenson School of Biomedical Engineering, University of OklahomaDepartment of Biochemistry and Molecular Biology, University of Texas Medical BranchSchool of Sustainable Chemical, Biological, and Materials Engineering, University of OklahomaStephenson School of Biomedical Engineering, University of OklahomaStephenson Cancer CenterSchool of Sustainable Chemical, Biological, and Materials Engineering, University of Oklahomahttps://doi.org/10.1186/s43556-024-00180-4
spellingShingle Alexis Woodward
Benjamin Southard
Sampurna Chakraborty
Aaron O. Bailey
Gabriela N. F. Faria
Patrick McKernan
Wajeeha Razaq
Roger G. Harrison
Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
Molecular Biomedicine
title Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
title_full Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
title_fullStr Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
title_full_unstemmed Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
title_short Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
title_sort correction annexin a5 dm1 protein drug conjugate for the treatment of triple negative breast cancer
url https://doi.org/10.1186/s43556-024-00180-4
work_keys_str_mv AT alexiswoodward correctionannexina5dm1proteindrugconjugateforthetreatmentoftriplenegativebreastcancer
AT benjaminsouthard correctionannexina5dm1proteindrugconjugateforthetreatmentoftriplenegativebreastcancer
AT sampurnachakraborty correctionannexina5dm1proteindrugconjugateforthetreatmentoftriplenegativebreastcancer
AT aaronobailey correctionannexina5dm1proteindrugconjugateforthetreatmentoftriplenegativebreastcancer
AT gabrielanffaria correctionannexina5dm1proteindrugconjugateforthetreatmentoftriplenegativebreastcancer
AT patrickmckernan correctionannexina5dm1proteindrugconjugateforthetreatmentoftriplenegativebreastcancer
AT wajeeharazaq correctionannexina5dm1proteindrugconjugateforthetreatmentoftriplenegativebreastcancer
AT rogergharrison correctionannexina5dm1proteindrugconjugateforthetreatmentoftriplenegativebreastcancer